- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Secondary-progressive Multiple Sclerosis in New Zealand
Total 516 results
-
EMD SeronoPfizerCompletedRelapsing-remitting Multiple SclerosisUnited States, United Kingdom, Argentina, Austria, Brazil, France, Germany, Italy, Netherlands, Russian Federation, Spain, Switzerland
-
EMD SeronoMerck KGaA, Darmstadt, Germany; Ono Pharmaceutical Co. LtdTerminatedMultiple SclerosisUnited States, Belgium, Canada, Czech Republic, Germany, Japan, Poland, Russian Federation, Spain, Ukraine, Greece
-
BiogenCompletedMultiple SclerosisUnited States, Italy, Hungary, United Kingdom, Spain, France, Australia, Germany, Canada, Switzerland, Argentina, Czech Republic, Croatia
-
BayerCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.TerminatedRelapsing-Remitting Multiple SclerosisUnited States, Albania, Belarus, Bosnia and Herzegovina, Bulgaria, Croatia, Estonia, Georgia, Greece, Latvia, Macedonia, The Former Yugoslav Republic of, Mexico, Moldova, Republic of, Montenegro, Poland, Romania, Russian... and more
-
BayerCompletedMultiple Sclerosis | Multiple Sclerosis, Relapsing-RemittingUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedMultiple SclerosisUnited States, Argentina, Austria, Belgium, Croatia, Finland, France, Germany, Ireland, Italy, Mexico, Poland, Puerto Rico, Russian Federation, Spain, Turkey
-
Kessler FoundationNational Multiple Sclerosis SocietyCompletedCognitive Impairment in Multiple SclerosisUnited States
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisSpain, Australia
-
BiogenElan PharmaceuticalsTerminatedRelapsing Remitting Multiple SclerosisUnited States, Czech Republic, Italy, Spain, Sweden, Latvia, Finland, Hungary, Poland, Slovenia, Australia, Canada, France
-
Ono Pharma USA IncCompletedMultiple SclerosisUnited States, Belgium, Canada, Czech Republic, Germany, Greece, Japan, Poland, Russian Federation, Spain, Ukraine
-
GlaxoSmithKlineCompletedMultiple Sclerosis, Relapsing-RemittingAustralia
-
Cornerstone Health Care, PABiogenCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisFrance, Italy, Spain, Czechia, Hungary, Austria, Belgium, Canada, Portugal, Slovakia, Slovenia
-
SanofiCompletedRelapsing Multiple SclerosisIndia
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisBelgium, Germany, Italy, Norway, France, Mexico, Australia, Spain, Portugal, Greece, Netherlands, United Kingdom, Czechia, Slovakia, Finland, Canada, Argentina, Brazil
-
EMD Serono Research & Development Institute, Inc.CompletedRelapsing-Remitting Multiple SclerosisCroatia, United States, Bulgaria, France, Italy, Russian Federation, Turkey, United Kingdom, Estonia, Germany, Latvia, Lithuania, Poland, Austria, Brazil, Canada, Finland, Portugal, Greece, Serbia, Denmark, Ukraine, Saudi Arabia, Lebanon and more
-
Genzyme, a Sanofi CompanyCompletedRelapsing Remitting Multiple SclerosisUnited States, Argentina, Australia, Belgium, Brazil, Canada, Czechia, Denmark, Germany, Israel, Italy, Mexico, Netherlands, Poland, Russian Federation, Spain, Sweden, Ukraine, United Kingdom
-
Kessler FoundationCelgene; Hackensack Meridian Health; St. Barnabas Medical CenterRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
GlaxoSmithKlineCompletedMultiple Sclerosis, Relapsing-RemittingAustralia
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedMultiple SclerosisUnited States, Bulgaria, Croatia, Czechia, Estonia, Georgia, Germany, Israel, Italy, Lithuania, North Macedonia, Poland, Puerto Rico, Romania, Russian Federation, Slovakia, South Africa, Spain, Ukraine
-
Mayo ClinicNational Institute of Neurological Disorders and Stroke (NINDS); National Institute... and other collaboratorsRecruitingAmyotrophic Lateral Sclerosis | Progressive Supranuclear Palsy (PSP) | Corticobasal Degeneration (CBD) | GRN Related Frontotemporal Dementia | Behavioral Variant Frontotemporal Dementia (bvFTD) | Semantic Variant Primary Progressive Aphasia (svPPA) | Nonfluent Variant Primary Progressive Aphasia... and other conditionsUnited States, Canada
-
Hoffmann-La RocheActive, not recruitingMultiple Sclerosis (MS)United States
-
BiogenAlkermes, Inc.CompletedMultiple SclerosisUnited States, Bulgaria, Poland, Belgium, Canada, Germany, Russian Federation, Serbia, Spain, Ukraine
-
Genentech, Inc.CompletedMultiple SclerosisUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapse-Remitting Multiple SclerosisUnited States
-
Helius Medical IncRecruitingGait Impairment Due to Mild/Moderate Multiple Sclerosis (MS)United States
-
Novartis PharmaceuticalsCompletedMultiple Sclerosis | Relapsing Multiple Sclerosis | Advancing Multiple SclerosisUnited States, Puerto Rico
-
BiogenElan PharmaceuticalsCompleted
-
Merck KGaA, Darmstadt, GermanyCompletedRelapsing Multiple Sclerosis (RMS)Germany, Poland
-
BiogenTerminatedRelapsing Multiple SclerosisUnited States
-
Universität MünsterRecruitingMultiple Sclerosis, Relapsing-RemittingGermany
-
ActelionCompletedMultiple SclerosisUnited States, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, Finland, France, Germany, Hungary, Israel, Italy, Netherlands, Poland, Romania, Russian Federation, Serbia, Spain, Sweden, Switzerland, Ukraine, United Kingdom
-
EMD SeronoTerminatedRelapsing Remitting Multiple SclerosisUnited States, Croatia, Bulgaria, Czech Republic, Italy, Mexico, Russian Federation, South Africa, Spain, Turkey, Hungary, Poland, Ukraine, Finland, United Kingdom, Greece, Serbia
-
Clene NanomedicineClene Australia Pty LtdTerminatedRelapsing Remitting Multiple Sclerosis | Optic Neuropathy | Optic; Neuritis, With DemyelinationUnited States, Canada, Australia
-
Mallinckrodt ARD LLCTerminatedMultiple Sclerosis, Relapsing-RemittingUnited States
-
GlaxoSmithKlineCompletedMultiple Sclerosis, Relapsing-RemittingAustralia
-
BayerCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
EMD SeronoCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
Genentech, Inc.CompletedMultiple Sclerosis, Relapsing-RemittingUnited States, Canada
-
TG Therapeutics, Inc.Active, not recruitingRelapsing Multiple Sclerosis (RMS)United States, Belarus, Croatia, Georgia, Poland, Russian Federation, Serbia, Ukraine
-
Genentech, Inc.Active, not recruitingMultiple Sclerosis, RelapsingUnited States, Puerto Rico, Kenya
-
BiogenCompletedRelapsing Multiple SclerosisUnited States, Germany, Russian Federation, India, New Zealand, Spain, Belgium, Colombia, Canada, Bulgaria, Serbia, Greece, Peru, Ukraine, Poland, United Kingdom, Croatia, France, Romania, Chile, Czech Republic, Mexico, Estonia, Georgia, Latv... and more
-
Hoffmann-La RocheCompletedMultiple Sclerosis, Relapsing-RemittingCanada, United States
-
BiogenElan PharmaceuticalsCompletedMultiple Sclerosis, Relapsing-RemittingUnited Kingdom, United States, Canada, Belgium, Czech Republic, France, Germany, Netherlands
-
BiogenCompletedRelapsing Multiple SclerosisUnited States, Croatia, Russian Federation, India, Spain, New Zealand, Canada, Belgium, Netherlands, Bulgaria, Serbia, Greece, Ukraine, Mexico, Georgia, Colombia, Germany, Poland, United Kingdom, Czech Republic, France, Chile, Romania, Eston... and more
-
Novartis PharmaceuticalsActive, not recruitingRelapse Remitting Multiple SclerosisUnited States, Puerto Rico
-
Rutgers, The State University of New JerseyCompletedMultiple SclerosisUnited States
-
Rutgers, The State University of New JerseyCompletedMultiple SclerosisUnited States
-
ActelionCompletedMultiple SclerosisPoland, Ukraine, United Kingdom, United States, Germany, Spain, Bulgaria, Romania, Serbia, Canada, Finland, Sweden, Russian Federation, Hungary, Czechia, Netherlands, Israel, Switzerland, Austria, France